These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 37205763)
1. Structure of the immunoregulatory sialidase NEU1. Gorelik A; Illes K; Mazhab-Jafari MT; Nagar B Sci Adv; 2023 May; 9(20):eadf8169. PubMed ID: 37205763 [TBL] [Abstract][Full Text] [Related]
2. Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent. Itoh K; Tsukimoto J Glycoconj J; 2023 Dec; 40(6):611-619. PubMed ID: 38147151 [TBL] [Abstract][Full Text] [Related]
3. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells. Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228 [TBL] [Abstract][Full Text] [Related]
4. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo. Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251 [TBL] [Abstract][Full Text] [Related]
5. Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization. Bonten EJ; Campos Y; Zaitsev V; Nourse A; Waddell B; Lewis W; Taylor G; d'Azzo A J Biol Chem; 2009 Oct; 284(41):28430-28441. PubMed ID: 19666471 [TBL] [Abstract][Full Text] [Related]
6. Cellular translocation and secretion of sialidases. Aljohani MA; Sasaki H; Sun XL J Biol Chem; 2024 Sep; 300(9):107671. PubMed ID: 39128726 [TBL] [Abstract][Full Text] [Related]
7. Lysosomal localization of Japanese medaka (Oryzias latipes) Neu1 sialidase and its highly conserved enzymatic profiles with human. Ryuzono S; Takase R; Oishi K; Ikeda A; Chigwechokha PK; Funahashi A; Komatsu M; Miyagi T; Shiozaki K Gene; 2016 Jan; 575(2 Pt 2):513-523. PubMed ID: 26432003 [TBL] [Abstract][Full Text] [Related]
8. Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in Karmakar J; Roy S; Mandal C Front Immunol; 2019; 10():2360. PubMed ID: 31649671 [TBL] [Abstract][Full Text] [Related]
10. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis. Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387 [TBL] [Abstract][Full Text] [Related]
11. Identification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytes. D'Avila F; Tringali C; Papini N; Anastasia L; Croci G; Massaccesi L; Monti E; Tettamanti G; Venerando B J Cell Biochem; 2013 Jan; 114(1):204-11. PubMed ID: 22903576 [TBL] [Abstract][Full Text] [Related]
12. Comparative enzymology, biochemistry and pathophysiology of human exo-alpha-sialidases (neuraminidases). Achyuthan KE; Achyuthan AM Comp Biochem Physiol B Biochem Mol Biol; 2001 May; 129(1):29-64. PubMed ID: 11337249 [TBL] [Abstract][Full Text] [Related]
13. New insights on the sialidase protein family revealed by a phylogenetic analysis in metazoa. Giacopuzzi E; Bresciani R; Schauer R; Monti E; Borsani G PLoS One; 2012; 7(8):e44193. PubMed ID: 22952925 [TBL] [Abstract][Full Text] [Related]
14. Galactosialidosis: historic aspects and overview of investigated and emerging treatment options. Annunziata I; d'Azzo A Expert Opin Orphan Drugs; 2017; 5(2):131-141. PubMed ID: 28603679 [TBL] [Abstract][Full Text] [Related]
15. Novel Nile tilapia Neu1 sialidases: Molecular cloning and biochemical characterization of the sialidases Neu1a and Neu1b. Honda A; Chigwechokha PK; Takase R; Hayasaka O; Fujimura K; Kotani T; Komatsu M; Shiozaki K Gene; 2020 Jun; 742():144538. PubMed ID: 32184168 [TBL] [Abstract][Full Text] [Related]
16. Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease. Du J; Shui H; Chen R; Dong Y; Xiao C; Hu Y; Wong NK Curr Issues Mol Biol; 2024 Jul; 46(8):8031-8052. PubMed ID: 39194692 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103 [TBL] [Abstract][Full Text] [Related]
18. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement. Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247 [TBL] [Abstract][Full Text] [Related]
19. Sialidase NEU3 and its pathological significance. Miyagi T; Yamamoto K Glycoconj J; 2022 Oct; 39(5):677-683. PubMed ID: 35675020 [TBL] [Abstract][Full Text] [Related]